The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats

被引:19
|
作者
Weber, Martin [1 ]
Chang, Wei-Li [1 ]
Breier, Michelle R. [1 ]
Yang, Alex [1 ]
Millan, Mark J.
Swerdlow, Neal R. [1 ]
机构
[1] UCSD Sch Med, Dept Psychiat, La Jolla, CA 92093 USA
关键词
Dopamine; D2; receptor; Prepulse inhibition; Schizophrenia; Sumanirole; NUCLEUS-ACCUMBENS; RECEPTOR; D3; PRAMIPEXOLE; ANTAGONISTS; MODELS; S33084;
D O I
10.1016/j.euroneuro.2010.02.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dopamine agonists reduce prepulse inhibition (PPI) of startle in rats. While it is used to predict antipsychotic efficacy, the specific receptor subtypes mediating this effect of dopamine agonists remain unclear. We characterized the effects of sumanirole, a highly selective 02 agonist, on PPI in rats. Sumanirole decreased PPI at 60-120 ms prepulse intervals, and increased PPI at 10-20 ms intervals. PPI deficits were antagonized by low doses of the preferential D2 antagonist L741626, supporting a D2 mechanism of action. Sumanirole is a valuable tool for parsing the role of dopamine receptor subtypes in the regulation of PPI. (C) 2010 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:421 / 425
页数:5
相关论文
共 50 条
  • [1] The Effects of the Dopamine D2 Agonist Sumanirole on Prepulse Inhibition in Rats
    Weber, Martin
    Chang, Wei-li
    Breier, Michelle R.
    Yang, Alex C.
    Lee, Kyounghee
    Millan, Mark J.
    Swerdlow, Neal R.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 73S - 73S
  • [2] PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats
    Martin-Iverson, MT
    Else, D
    [J]. PSYCHOPHARMACOLOGY, 2000, 151 (01) : 38 - 48
  • [3] PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats
    M.T. Martin-Iverson
    D. Else
    [J]. Psychopharmacology, 2000, 151 : 38 - 48
  • [4] Effects of the dopamine D2 agonist, quinpirole, on time and number processing in rats
    Santi, A
    Coppa, R
    Ross, L
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 68 (01) : 147 - 155
  • [5] Sumanirole: The first highly A D2 selective dopamine receptor agonist intended for the treatment of Parkinson's disease
    McCall, RB
    Nichols, NF
    Svensson, KA
    Meglasson, MD
    Huff, RM
    [J]. MOVEMENT DISORDERS, 2002, 17 : S50 - S50
  • [6] Deficient prepulse inhibition induced by selective breeding of rats can be restored by the dopamine D2 antagonist haloperidol
    Hadamitzky, Martin
    Harich, Silke
    Koch, Michael
    Schwabe, Kerstin
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2007, 177 (02) : 364 - 367
  • [7] Dopamine D2 agonist priming in intact and dopamine-lesioned rats
    Kostrzewa, RM
    Kostrzewa, JP
    Nowak, P
    Kostrzewa, RA
    Brus, R
    [J]. NEUROTOXICITY RESEARCH, 2004, 6 (06) : 457 - 462
  • [8] Dopamine D2 agonist priming in intact and dopamine-lesioned rats
    Richard M. Kostrzewa
    John P. Kostrzewa
    Przemyslaw Nowak
    Rose Anna Kostrzewa
    Ryszard Brus
    [J]. Neurotoxicity Research, 2004, 6 : 457 - 462
  • [9] TERGURIDE, A DOPAMINE D2 PARTIAL AGONIST, AS A DISCRIMINATIVE STIMULUS IN RATS
    YAMAGUCHI, M
    KIMURAIWASAKI, K
    AKAI, T
    NAKADA, Y
    NAKAGAWA, H
    [J]. BEHAVIOURAL PHARMACOLOGY, 1991, 2 (03): : 233 - 240
  • [10] ENDOCRINE AND NEUROCHEMICAL EFFECTS OF (+)-PHNO, A DOPAMINE D2 AGONIST
    GUST, CM
    HEMRICKLUECKE, SK
    FULLER, RW
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1989, 75 (01) : 11 - 20